RGCIRC Improves Breast Cancer Treatment at Breast Cancer Update Conference 2024

NEW DELHI: The Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) successfully organized the "Breast Cancer Update Conference 2024" on June 15th and 16th. This event gathered prominent experts, researchers, healthcare professionals, and faculty from India and around the world to delve into recent advancements in breast cancer research. Over two days, the conference highlighted significant findings from major global oncology conferences including ASCO, ESMO, and SABCS.

Under the patronage of chairman Mr. Rakesh Chopra, the conference featured sessions led by experts focusing on new therapies, precision medicine, and patient-centric care. It included panel discussions, interactive workshops, and opportunities for collaboration to advance knowledge in areas such as early-stage breast cancer, metastatic breast cancer, triple-negative breast cancer, and innovative treatments like immunotherapy and precision medicine.

Renowned oncologists presented significant findings from recent studies and latest trials on targeted therapies, immunotherapy like Pembrolizumab, cyclin inhibitor tablets and many new drugs and surgical procedures along with radiation techniques and investigations which have made revolutionary changes in the outcome of breast cancer management. These presentations provided valuable insights into innovative treatments and patient care strategies.

Dr. D C Doval, Chair Medical Oncology & Chief of Breast & Thoracic Services, RGCIRC and Organizing Chairman, emphasized the importance of such platforms for sharing knowledge and driving advancements in breast cancer treatment: "The Breast Cancer Update Conference 2024 provided an invaluable opportunity for professionals to learn from each other and stay abreast of the latest research and clinical practices worldwide. Our goal is to advance our collective efforts in breast cancer care and improve patient outcomes. Together, we can make significant strides in the fight against breast cancer."

Dr. Pankaj Goyal, Senior Consultant, Medical Oncology, RGCIRC, highlighted the success of the event saying: "Our goal is to ensure that the latest advancements in breast cancer research are rapidly translated into clinical practice. This conference has been instrumental in bridging the gap between research and patient care, and we are committed to continuing this momentum."

Interactive panel discussions allowed for robust exchanges of ideas and experiences among top oncologists, researchers, and clinicians. Panels covered critical subjects such as high-risk breast cancer, metastatic breast cancer, and the evolving role of immunotherapy in treatment protocols.

Dr. (Prof) Sudhir Kumar Rawal, Medical Director highlighted that the conference has been instrumental in bridging the gap between research and patient care while Dr. Vineet Talwar, Director, Medical Oncology, RGCIRC expressed optimism about the impact of the conference. Dr. A.K. Dewan, Director Surgical Oncology, RGCIRC emphasized that the Breast Cancer Update Conference 2024 represents the ongoing commitment of RGCIRC to addressing the complexities of breast cancer.